期刊文献+

淋巴管生成因子对乳腺癌淋巴结转移的影响

The impact of VEGF-C on lymph-node metastasis of breast cancer
原文传递
导出
摘要 目的 探讨淋巴管生成因子(VEGF-C)对乳腺癌淋巴结转移的影响.方法 采用免疫组织化学PV9000法对人乳腺浸润性导管癌和乳腺纤维瘤、乳腺病组织的石蜡切片分别进行检测,观察其VEGF-C的表达状态.结果 20例乳腺纤维瘤及乳腺病VEGF-C均为阴性,80例乳腺癌组织VEGF-C阳性率为72.5%(58/80);VEGF-C主要存在于癌细胞中,正常的乳腺纤维瘤及乳腺病的胞质中不表达VEGF-C.结论 乳腺癌细胞中存在VEGF-C,其表达状态与乳腺癌淋巴结转移关系密切.检测VEGF-C蛋白表达可能对人乳腺癌淋巴结转移具有预测和治疗价值. Objective To investigate the VEGF-C on lymph node metastasis of b-reast cancer.Methods A group of immune PV9000 law on human breast infiltrating ductal breast cancer and fibroids,breast disease organizations paraffin sections were detected on the expression of VEGF-C status.Results 20 patients with breast fibroids and breast disease were negative VEGF-C,80 cases of breast cancer VEGF-C positive rate was 72.5%(58/80);VEGF-C exists primarily on the cancer cells and normal breast fibroids and in the cytoplasm of breast disease is not the expression of VEGF-C.Conclusion Breast cancer cells in the VEGF-C,the expression of close ties with lymph node metastasis.Detection of VEGF-C expression in human breast cancer may predict lymph node metastasis,and therapeutic value.
作者 吕俊 赵瑛
出处 《肿瘤研究与临床》 CAS 2007年第z1期-,共3页 Cancer Research and Clinic
  • 相关文献

参考文献18

  • 1Joukov V,Pajusola K,Kaipainen A. A novel vascular endothelialgrowth factor,VEGF-C,is a ligand for the Fit4(VRGFR-3)and KDR(VEGFR-2)receptor tyrosine kinases[J].European Molecular Biology Organization Journal,1996,(02):290-298.
  • 2Toi M,Kashitani J,Tomonaga T. Tumor angiogenesis is an independent prognostic indicator in primary breast carcinoma[J].International Journal of Cancer,1993,(03):371-374.doi:10.1002/ijc.2910550305.
  • 3Ogawa Y,Chung YS,Nakata B. Microvessel quantitation in invasive breast cancer by staining for factor 2related antigen[J].British Journal of Cancer,1995,(06):1297-1301.
  • 4Kinoshita J,Kitamura K,Kabashina A. Clincal signifcance of vascular endothelial growth factor-C(VEGF-C)in breast cancer[J].Breast Cancer Research and Treatment,2001,(02):159-164.doi:10.1023/A:1010692132669.
  • 5Valtola R,Salven P,Heikkila P. VEGFR-3 and its ligand VEGF-C are associated with angiogenesis in breast cancer[J].AMERICAN JOURNAL OF PATHOLOGY,1999,(05):1381-1390.
  • 6Maehara Y,Oshior T,Baba H. Lymphatic invasiion and potential for tumor growth and metastasis in patients with gastric cancer[J].Surgery,1995,(04):380-385.doi:10.1016/S0039-6060(05)80056-X.
  • 7Saaristo A,Karpanen T,Alitalo K. Mechanims of angiogenesis and their use in the in hibition of tumor growth and metastasis[J].Oncogene,2000,(53):6122-6129.doi:10.1038/sj.onc.1203969.
  • 8Rosen PP,Groshen S,Salgo P. Pathological prognostic factors in Stage(T1N0M0)Iand Stage Ⅱ(T1N1M0)breast carcinoma:a study of 644 patients with median follow-up of 18 years[J].Journal of Clinical Oncology,1989,(09):1239-1251.
  • 9Lymboussaki A,Partanen TA,Olofsson B. Expression of the vascular endothelial growth factor receptor VEGFR-3 in lymphatic endothelium of the skin and in vascular tumors[J].American Journal of Pathology,1998,(02):395-403.
  • 10曾谷清,王汉群,方松清,谷依学,邹飞燕,高勇强.乳腺癌组织p16蛋白和VEGF的表达及其临床意义[J].中国医师杂志,2004,6(2):175-178. 被引量:9

二级参考文献73

  • 1Xiu-Sheng He Qi Su Zhu-Chu Chen Xiu-Tao He Zhi-Feng Long Hui Ling Liang-Run Zhang Oncology Institute,Nanhua University,Hengyang 421001,Hunan Province,ChinaOncology Institute,Center South University,Changsha 410078,Hunan Province,China Department of Gastroenterology,First People’s Hospital of Changde City,Changde 415003,Hunan Province,China.Expression,deleton and mnutation of ρ16 gene in human gastric cancer[J].World Journal of Gastroenterology,2001,7(4):515-521. 被引量:40
  • 2高朋根,苏蕴,高友春,刘习昌,王继信,张友会.津白Ⅱ小鼠自发乳癌(ⅥTA_2MA-891)高自发肺转移模型[J].中国医学科学院学报,1994,16(2):147-152. 被引量:12
  • 3[1]Folkman J. What is the evidence that tumors are angiogenesisdependent? J Natl Cancer Inst, 1990, 82: 4~ 7.
  • 4[2]Leung DW, Cachianes G, Kuang WJ, et al. Vascular endothe lial growth factor is a secreted angiogenic mitogen. Science, 1989,246:1306~ 1309.
  • 5[3]Keck PJ, Hauser SD, Krivi G , et al. Vascular permeability fac tor, an endothelial cell mitogen related to PDGF. Science,1989,240: 1309~1312.
  • 6[4]De Vries C, Escobedo JA, Ueno H, et al. The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science, 1992, 255:989~993.
  • 7[5]Collins P. Characterization of the increase in vascular permea bility induced by vascular permeability factor in vivo. Br J Pharmacol, 1993, 109: 195~199.
  • 8[6]Nagy J. Pathogenesis of ascites tumor growth: vascular perme ability factor, vascular hyperpermeability, and ascites fluid ac cumulation. Cancer Res, 1995, 55: 360~368.
  • 9[7]Harold F. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. AmJ Pathol, 1995, 146:1029~ 1039.
  • 10[8]Mandriiota SJ , Seghezzi G, Vassalli JD, et al. Vascular endo thelial growth factor increase urokinase receptor expression in vascular endothelial cells. J Bio Chem, 1995, 270:9707 ~ 9716.

共引文献112

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部